Literature DB >> 15322820

[Tumor classifications].

C Wittekind1, I Tischoff.   

Abstract

The correct use of tumor classifications is one of the key elements of adequate oncological treatment. Tumor classifications comprise: localization, typing, grading staging and stage grouping, classification after neoadjuvant radio(chemo)therapy, TNM classification and R classification. For easier identification and better documentation it is advisable to have a summary of tumor classifications at the end of each tumor concerning pathology report. Experience in clinical use has shown that classification may be incomplete or inadequately used. Not infrequently they are reported in a way which is open for misinterpretation. Some possible mistakes and misuse of tumor classifications are discussed. Users, among which are clinicians and pathologists, have to bear in mind the limitations of tumor classifications. These are for example reflected by the difficulty to classify single tumor entities in a correct way.

Entities:  

Mesh:

Year:  2004        PMID: 15322820     DOI: 10.1007/s00292-004-0716-3

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  9 in total

1.  Gastric carcinoma. A pathobiological classification.

Authors:  S C Ming
Journal:  Cancer       Date:  1977-06       Impact factor: 6.860

2.  Micrometastatic tumour cells in bone marrow of patients with gastric cancer: methodological aspects of detection and prognostic significance.

Authors:  G Schlimok; I Funke; K Pantel; F Strobel; F Lindemann; J Witte; G Riethmüller
Journal:  Eur J Cancer       Date:  1991       Impact factor: 9.162

3.  [Current TNM aspects. 5. TNM classification and stage grouping].

Authors:  P Hermanek; C Wittekind; H J Seib
Journal:  Zentralbl Chir       Date:  1997       Impact factor: 0.942

4.  Residual tumor (R) classification and prognosis.

Authors:  P Hermanek; C Wittekind
Journal:  Semin Surg Oncol       Date:  1994 Jan-Feb

5.  The pathologist and the residual tumor (R) classification.

Authors:  P Hermanek; C Wittekind
Journal:  Pathol Res Pract       Date:  1994-02       Impact factor: 3.250

Review 6.  Selection of appropriate cellular and molecular biologic diagnostic tests in the evaluation of cancer.

Authors:  C M Fenoglio-Preiser
Journal:  Cancer       Date:  1992-03-15       Impact factor: 6.860

7.  [Importance of tumor growth and spread for surgical radical excision].

Authors:  C Wittekind
Journal:  Zentralbl Chir       Date:  1993       Impact factor: 0.942

8.  Evaluation of resection margins after breast conservative surgery with monoclonal antibodies.

Authors:  U Veronesi; G Farante; V Galimberti; M Greco; A Luini; V Sacchini; S Andreola; F Leoni; S Ménard; M Ronco
Journal:  Eur J Surg Oncol       Date:  1991-08       Impact factor: 4.424

Review 9.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.

Authors:  N L Harris; E S Jaffe; H Stein; P M Banks; J K Chan; M L Cleary; G Delsol; C De Wolf-Peeters; B Falini; K C Gatter
Journal:  Blood       Date:  1994-09-01       Impact factor: 22.113

  9 in total
  1 in total

1.  [Prognostic factors for oral squamous cell carcinoma].

Authors:  A W Eckert; M H W Lautner; R Dempf; J Schubert; U Bilkenroth
Journal:  Chirurg       Date:  2009-02       Impact factor: 0.955

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.